SoFi shares rise as record revenue, member growth drive strong Q3 results
BLOOMFIELD, Conn. - The Cigna Group (NYSE:CI) announced Wednesday that its Board of Directors has declared a quarterly cash dividend of $1.51 per share of common stock, maintaining its impressive 44-year streak of consecutive dividend payments. The company’s current dividend yield stands at 2.02%.
The dividend will be payable on December 18, 2025, to shareholders of record as of the close of business on December 4, 2025, according to a press release statement from the company. InvestingPro data shows the company has raised its dividend for 4 consecutive years.
Cigna Group is a global health company with approximately 180 million customer relationships worldwide. The company operates through its Cigna Healthcare and Evernorth Health Services divisions, maintaining sales capabilities in more than 30 markets and jurisdictions.
The company’s stock trades on the New York Stock Exchange under the ticker symbol CI.
In other recent news, Cigna Corporation has made a significant move by investing $3.5 billion in Shields Health Solutions to expand its specialty pharmacy operations. This investment is being facilitated through Cigna’s Evernorth division and involves preferred stock, as noted by Bernstein SocGen Group, which maintains a Market Perform rating with a $346 price target on Cigna shares. Meanwhile, Wolfe Research has adjusted its price target for Cigna, lowering it to $325 from $345, while still maintaining an Outperform rating. Despite this adjustment, Wolfe Research considers Cigna stock to be undervalued at approximately nine times its revised 2026 earnings per share estimate.
UBS continues to hold a Buy rating for Cigna, with a price target of $390, citing the company’s resilience in the Managed Care sector and its long-term earnings growth potential. UBS highlighted Cigna’s recovery in margin within its stop-loss business, ongoing share buybacks, and opportunities in specialty pharmacy as key factors. Cantor Fitzgerald reiterated its Overweight rating on Cigna with a $365 price target, following the company’s strategic exit from an Illinois county. These developments underscore Cigna’s strategic initiatives and analysts’ varied perspectives on its future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.